Details

Autor(en) / Beteiligte

• Lersy, François
• Benotmane, Ilies
• Helms, Julie
• Collange, Olivier
• Schenck, Maleka
• Brisset, Jean-Christophe
• Chammas, Agathe
• Willaume, Thibault
• Lefebvre, Nicolas
• Solis, Morgane
• Hansmann, Yves
• Fabacher, Thibaut
• Caillard, Sophie
• Mertes, Paul Michel
• Pottecher, Julien
• Schneider, Francis
• Meziani, Ferhat
• Fafi-Kremer, Samira
• Kremer, Stéphane

Titel

Cerebrospinal Fluid Features in Patients With Coronavirus Disease 2019 and Neurological Manifestations: Correlation with Brain Magnetic Resonance Imaging Findings in 58 Patients

Ist Teil von

• The Journal of infectious diseases, 2021-02, Vol.223 (4), p.600-609

Ort / Verlag

US: Oxford University Press

Erscheinungsjahr

2021

Link zum Volltext

Quelle

Oxford Journals 2020 Medicine

Beschreibungen/Notizen

• Abstract Background Neurological manifestations are common in patients with coronavirus disease 2019 (COVID-19), but little is known about pathophysiological mechanisms. In this single-center study, we examined neurological manifestations in 58 patients, including cerebrospinal fluid (CSF) analysis and neuroimaging findings. Methods The study included 58 patients with COVID-19 and neurological manifestations in whom severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reverse-transcription polymerase chain reaction screening and on CSF analysis were performed. Clinical, laboratory, and brain magnetic resonance (MR) imaging data were retrospectively collected and analyzed. Results Patients were mostly men (66%), with a median age of 62 years. Encephalopathy was frequent (81%), followed by pyramidal dysfunction (16%), seizures (10%), and headaches (5%). CSF protein and albumin levels were increased in 38% and 23%, respectively. A total of 40% of patients displayed an elevated albumin quotient, suggesting impaired blood-brain barrier integrity. CSF-specific immunoglobulin G oligoclonal band was found in 5 patients (11%), suggesting an intrathecal synthesis of immunoglobulin G, and 26 patients (55%) presented identical oligoclonal bands in serum and CSF. Four patients (7%) had a positive CSF SARS-CoV-2 reverse-transcription polymerase chain reaction. Leptomeningeal enhancement was present on brain MR images in 20 patients (38%). Conclusions Brain MR imaging abnormalities, especially leptomeningeal enhancement, and increased inflammatory markers in CSF are frequent in patients with neurological manifestations related to COVID-19, whereas SARS-CoV-2 detection in CSF remained scanty. Cerebrospinal fluid abnormalities were frequent in patients with neurological manifestations related to coronavirus disease 2019, whereas severe acute respiratory syndrome coronavirus 2 detection in cerebrospinal fluid remained scanty.